Catalyst Pharmaceuticals, Inc. (CPRX) NASDAQ

22.60

+0.0879(+0.39%)

Updated at November 20 01:51PM

Currency In USD

Valuation

Market Cap2.47B
Enterprise Value1.96B
P/E Ratio12.89
PEG Ratio3.74
Price/Sales Ratio4.86
Price/Book Ratio3.05
Enterprise/Revenue3.67
Enterprise/EBITDA7.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.38
Operating Margin0.45

Management Effectiveness

Return On Assets0.21
Return On Equity0.26

Income Statement

Revenue491.73M
Revenue/Share4.72
Gross Profit422.89M
EBITDA232.9M
Net Income163.89M
Diluted EPS1.31

Balance Sheet

Total Cash689.89M
Total Cash/Share5.63
Total Debt2.89M
Total Debt/Equity0
Current Ratio6.62
Book Value Per Share7.51

Price History

52-Week Change8.18
52-Week High26.58
52-Week Low19.05
Moving Average 50 Days20.91
Moving Average 200 Days22.03

Statistics

Average Volume1.48M
Shares Outstanding122.91M
% Held by Institutions84.46

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A